Global Breast Reconstruction Market - Snapshot

The global breast reconstruction market is driven by rise in prevalence of breast cancer, increase in demand for acellular dermal matrix, and launch of new products by key players. Additionally, increase in health care expenditure in emerging economies such as China, Australia, and India, and rise in emphasis on safe & reliable surgical procedures are projected to contribute to the growth of the global market during the forecast period. However, product recalls by regulatory authorities, strict regulatory requirements, and complications associated with the use of breast implants & other products are the major factors anticipated to restrain the global market. For instance, in February 2014, the ANSM recalled Cereform silicone gel-filled breast implants, as the sterilization process for the manufacture of the implant was not as per the set international standards. Changes in nipple & breast sensation, capsular contracture, scar tissue formation, and rupture of breast implants are the various complications associated with breast implants anticipated to hamper the growth of the market.

breast reconstruction market

In terms of product, the global breast reconstruction market has been classified into breast implants, tissue expanders, acellular dermal matrix (ADM), and others. The breast implants segment is projected to account for major share of the market by 2026. Growth of the segment is attributed to increase in demand for silicone breast implants and rise in the number breast reconstruction procedures, especially in the developed countries in North America and Europe. The acellular dermal matrix segment is anticipated to expand at a high CAGR from 2018 to 2026. Increase in the number of plastic surgeons using acellular dermal matrices is expected to propel the segment during the forecast period. Based on end-user, the market has been divided into hospitals and ambulatory surgical centers. The ambulatory surgical centers segment is likely to grow at a rapid pace due to increase in the number of women preferring these centers for breast reconstruction and rise in surgical procedures in ambulatory care centers.

In terms of region, the global breast reconstruction market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the global market in 2017. The market in the region is anticipated to be driven by extensive use of silicone breast implants and launch of acellular dermal matrices especially for breast reconstruction. For instance, AirXpanders, Inc., a manufacturer of medical devices for breast reconstruction, launched AeroForm Tissue Expander System in the U.S. for breast reconstruction. The product was previously launched in Europe and Australia. Moreover, significant increase in the number of breast reconstruction procedures in the U.S. is expected to drive demand for breast implants. According to the American Society of Plastic Surgeons, the procedural volume of breast reconstruction has increased steadily by 3% in the U.S. from 2000 to 2015. Most of the patients prefer breast reconstruction after bilateral mastectomy.

The breast reconstruction market in Europe is driven by increase in the number of breast reconstruction procedures in Germany and Italy, and product line expansion by prominent players. According to the American Society of Plastic Surgeons, 89,925 and 94,845 breast procedures were performed in Germany and Italy, respectively, in 2017. In October 2017, Integra LifeSciences launched Integra SurgiMend PRS, an acellular dermal tissue matrix, in Europe to expand its acellular dermal tissue matrix product line and gain competitive advantage in the highly competitive market of breast reconstruction.

Major players operating in the global breast reconstruction market include Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra, Inc., GC Aesthetics, Establishment Labs S.A., POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe.          

Global Breast Reconstruction Market: Overview 

This report analyzes the current and future scenario of the global breast reconstruction market. Growth of the market is attributed to rise in prevalence of breast cancer, surge in demand for breast implants & acellular dermal matrix, and increase in focus on research and development activities. Additionally, rise in focus on women’ health and increase in awareness about breast reconstruction after mastectomy fuel the growth of the global breast reconstruction market. According to Breastcancer.org, in the U.S., nearly 1 in 8 women develop invasive breast cancer, accounting to about 12.4% of cases of breast cancer globally. Moreover, breast cancer is a common type of cancer diagnosed among women in the U.S. However, product recalls by regulatory authorities and complications due to breast implants & other products are expected to hamper the growth of the global market. 

The global breast reconstruction market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global breast reconstruction market. 

Global Breast Reconstruction Market: Key Segments 

In terms of product, the global breast reconstruction market has been classified into breast implants, tissue expanders, acellular dermal matrix (ADM), and others. The acellular dermal matrix segment is projected to expand at the fastest CAGR during the forecast period. Large number of manufacturers focusing on development of dermal matrices for indications such as breast reconstruction and hernia repair is a major factor propelling the segment. Usage of acellular dermal matrix in breast reconstruction by plastic surgeons has increased, especially in the developed countries such as the U.S. Based on end-user, the global market has been divided into hospitals and ambulatory surgical centers. The ambulatory surgical centers segment is anticipated to experience significant growth in terms of revenue and market share during the forecast period. The segments have been analyzed based on available products used during breast reconstruction surgeries for the treatment of any breast deformities, improve esthetic appearance, and reconstruction of breast after mastectomy. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026 along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. 

Global Breast Reconstruction Market: Regional Outlook 

In terms of region, the global breast reconstruction market has been segmented into five major regions: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026 along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report profiles major players in the global breast reconstruction market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Players profiled in the report include Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra, Inc., GC Aesthetics, Establishment Labs S.A., POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe. 

The global breast reconstruction market has been segmented as below:

  • Global Breast Reconstruction Market, by Product
    • Breast Implants
    • Tissue Expanders
    • Acellular Dermal Matrix (ADM)
    • Others
       
  • Global Breast Reconstruction Market, by End-user
    • Hospitals
    • Ambulatory Surgical Centers
       
  • Global Breast Reconstruction Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • Italy
      • France
      • Spain
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Israel
      • Rest of Middle East & Africa
.